Clinical Trial Update: Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients [Phase 1]

View source ↗

Summary

Phase Ib study evaluating the combination of sunitinib with radiation therapy for cancer has completed, including head and neck cancer and other neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nervous System Neoplasms
• Pelvic Neoplasms
• Thoracic Neoplasms

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Cancer, Head and Neck Cancer | Phase 1 | Status: COMPLETED